pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

Trump administration ends contracts with two No Surprises Act arbitrators over performance failures

Nov 5, 2026·read at STAT ↗RegulatoryNegative

The federal government announced that two organizations that handle disputes under the No Surprises Act will no longer be allowed to accept new cases, saying they failed to meet required performance standards.

The entities affected are Island Peer Review Organization (IPRO) and Network Medical Review Company.

The move follows a STAT investigation that reported the arbitrators were generating large profits while frequently ruling in favor of clinicians in billing disputes.

Both firms have the right to appeal the administration’s decision.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Two No Surprises Act arbitrators lose government contracts to decide payment disputes”

read at STAT ↗
470 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Approval

related stories

  • Apr 28Rocket's PRV goes for $180M; Oruka targets $500M offeringEndpoints
  • Apr 28STAT+: Boehringer’s obesity drug shows 16.6% weight loss; more data neededSTAT
  • Apr 28FDA claims trial 'manipulation' tainted approval of ChemoCentryx drugEndpoints
  • Apr 28Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead.BioPharma Dive
  • Apr 27Veradermics soars on positive data for baldness treatmentBioPharma Dive